TABLE 4.
Patient attrition with the various analysesa
| Day | Total no. of patients enrolled (% lost) | No. of patients enrolled (% lost) for indicated analysis and method
|
|||||
|---|---|---|---|---|---|---|---|
| Kaplan-Meier
|
Per-protocol
|
||||||
| Method 1 | Method 2 | No PCR genotyping | Method 1 | Method 2 | No PCR genotyping | ||
| 0 | 2,576 | ||||||
| 14 | 2,364 (8) | 2,544 (1) | 2,364 (8) | ||||
| 28 | 2,287 (11) | 2,433 (6) | 2,183 (15) | 2,176 (15) | 1,926 (25) | ||
a
Method 1 (cases unresolved by PCR excluded) and method 2 (cases unresolved by PCR and new infections both excluded) were applied to Kaplan-Meier and evaluability (per-protocol) data sets after PCR genotyping. No genotyping was done until day 14.